CareDx Analyst Price Targets - Benzinga

CareDx Inc

CDNANASDAQ

Trade with Public

Trade with Public

$64.02

-0.58-0.9%

In chiusura: Sep 29, 5:00 PM EST

$64.00

-0.02-0.03%

Post-mercato: 6:09 PM EST

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Opzioni Rapporto azionario

CareDx Analyst Price Targets

Wall Street analyst price targets and consensus rating for CareDx (CDNA).

Price Target Range — 11 Quarters

Analyst Consensus — 8 Analysts

5Buy

3Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$39Upside to Avg. PT-39.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 24, 2026	BTIG	Mark Massaro	PT Raise	Buy	$60→$74
Sep 2, 2026	Canaccord Genuity	Kyle Mikson	Initiate	Buy	$65
Aug 6, 2026	BTIG	Mark Massaro	PT Raise	Buy	$45→$60
Jul 31, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Neutral	$46
Jul 16, 2026	BTIG	Mark Massaro	PT Raise	Buy	$28→$45
Apr 29, 2026	BTIG	Mark Massaro	PT Raise	Buy	$26→$28
Feb 26, 2026	BTIG	Mark Massaro	PT Raise	Buy	$25→$26
Feb 25, 2026	Wells Fargo	Brandon Couillard	PT Raise	Equal-Weight	$18→$21
Dec 15, 2025	Wells Fargo	Brandon Couillard	PT Raise	Equal-Weight	$14→$18
Nov 6, 2025	BTIG	Mark Massaro	PT Raise	Buy	$22→$25
Sep 23, 2025	BTIG	Mark Massaro	Maintained	Buy	$22
Sep 12, 2025	BTIG	Mark Massaro	Maintained	Buy	$22
Aug 26, 2025	William Blair	Andrew Brackmann	Initiate	Market Perform	—
Aug 8, 2025	Wells Fargo	Brandon Couillard	PT Cut	Equal-Weight	$19→$14
Jul 18, 2025	Craig-Hallum	Connor Chamberlain	PT Cut	Buy	$40→$26
May 5, 2025	Stephens & Co.	Mason Carrico	Maintained	Overweight	$40
May 5, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Neutral	$25
Apr 17, 2025	Goldman Sachs	Matthew Sykes	PT Cut	Buy	$34→$26
Mar 3, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Neutral	$26→$25
Feb 27, 2025	Stephens & Co.	Mason Carrico	Maintained	Overweight	$40

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Maintains Buy on CareDx, Raises Price Target to $74

BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $60 to $74.

Benzinga Newsdesk

Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently

CMS aligns 2027 clinical lab fees with private payors to save $1 billion, yielding positive updates for CareDx and BillionToOne tests.

Vandana Singh

PRO
Canaccord Genuity Initiates Coverage On CareDx with Buy Rating, Announces Price Target of $65

Canaccord Genuity analyst Kyle Mikson initiates coverage on CareDx (NASDAQ:CDNA) with a Buy rating and announces Price Target of $65.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on CareDx, Raises Price Target to $60

BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $45 to $60.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Neutral on CareDx, Maintains $46 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates CareDx (NASDAQ:CDNA) with a Neutral and maintains $46 price target.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on CareDx, Raises Price Target to $45

BTIG analyst Mark Massaro maintains CareDx (NASDAQ:CDNA) with a Buy and raises the price target from $28 to $45.

Benzinga Newsdesk